EMA reviewing MAA from Amgen, UCB for osteoporosis candidate Evenity

Amgen Inc. (NASDAQ:AMGN) and UCB S.A. (Euronext:UCB) said EMA accepted for review an

Read the full 137 word article

User Sign In